<DOC>
	<DOC>NCT00171145</DOC>
	<brief_summary>This study will assess the efficacy of a 12-week treatment with darifenacin in increasing warning time, the time from first sensation of urgency to voiding, in patients with OAB.</brief_summary>
	<brief_title>A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Darifenacin</mesh_term>
	<criteria>Three symptoms of OAB (urge incontinence, frequency and urgency) for at least six months prior to Visit 2. Patients capable of independent toileting and able of independently completing the patient diary. Patients in whom the use of anticholinergic drugs was contraindicated Evidence of severe liver disease Patients with other clinically significant urinary or gynecological conditions Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Overactive Bladder, incontinence, antimuscarinic, warning time, darifenacin</keyword>
</DOC>